Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:
|}
|}


==Recommendations for Reintervention in Patients With Right Ventricular–Pulmonary Artery Conduit or Bioprosthetic Pulmonary Valve Stenosis==
== Recommendations for Reintervention in Patients With Right Ventricular–Pulmonary Artery Conduit or Bioprosthetic Pulmonary Valve Stenosis ==


{|class="wikitable"
{| class="wikitable"
|-
|-
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
Line 20: Line 20:
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Surgeons with training and expertise in CHD should perform operations for patients with severe pulmonary
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Surgeons with training and expertise in CHD should perform operations for patients with severe pulmonary
prosthetic valve stenosis (peak gradient greater than 50 mm Hg) or conduit regurgitation and any of the following:<nowiki>"</nowiki>
prosthetic valve stenosis (peak gradient greater than 50 mm Hg) or conduit regurgitation and any of the following:<nowiki>"</nowiki>
a. Decreased exercise capacity.([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])
a. Decreased exercise capacity.([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])



Revision as of 18:55, 5 October 2012

Right ventricular outflow tract obstruction Microchapters

Home

Patient Information

Overview

Anatomy of Pulmonary Valve

Classification

Pulmonary valve stenosis
Pulmonary subvalvular stenosis
Pulmonary supravalvular stenosis
Pulmonary atresia

Pathophysiology

Causes

Differentiating Right ventricular outflow tract obstruction from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac Catheterization

Pulmonary Angiography

Treatment

Indications For Surgery

Surgery

Pre-Operative A/P

Post-Operative A/P

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pulmonary artery conduits/Prosthetic Valves

Double-Chambered Right Ventricle

Case Studies

Case #1

Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve

CDC on Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve

Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve in the news

Blogs on Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve

Directions to Hospitals Treating Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve

Risk calculators and risk factors for Right ventricular outflow tract obstruction in right ventricular-pulmonary artery conduits or bioprosthetic valve

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Recommendation for Evaluation and Follow-Up After Right Ventricular-Pulmonary Artery Conduit or Prosthetic Valve[1]

Class I
"1. After surgical relief of RVOT obstruction with a conduit or prosthetic valve, patients should be followed up on a 1- to 2-year basis with echocardiographyDoppler assessment of RV systolic pressure and function, as well as a measurement of the gradient across the RVOT. (Level of Evidence: C) "

Recommendations for Reintervention in Patients With Right Ventricular–Pulmonary Artery Conduit or Bioprosthetic Pulmonary Valve Stenosis

Class I
"1. Surgeons with training and expertise in CHD should perform operations for patients with severe pulmonary

prosthetic valve stenosis (peak gradient greater than 50 mm Hg) or conduit regurgitation and any of the following:"

a. Decreased exercise capacity.(Level of Evidence: C)

b. Depressed RV function. (Level of Evidence: C)

c. At least moderately enlarged RV end-diastolic size.(Level of Evidence: C)

d. At least moderate TR. (Level of Evidence: C)

References

Template:WH Template:WS